CD163 and cancer: In contrast, tumoricidal M1-like macrophages, which express high levels of TNF, iNOS, and MHC molecules and low levels of ARG1, IL-10, CD163, and CD206 (26), play roles in reversing immune suppression in the TME and enhancing macrophage- or T cell-mediated killing of cancer cells.